What is Parable?
Parable operates at the intersection of biotechnology and consumer wellness, providing a specialized daily nutritional scoop designed to optimize cognitive function. Headquartered in Atlanta, Georgia, the company addresses the growing demand for science-backed brain health solutions. By simplifying complex nutritional requirements into a single, accessible product, Parable has carved out a distinct niche in the competitive health and wellness landscape, appealing to consumers seeking both convenience and efficacy in their daily health regimens.
How much funding has Parable raised?
Parable has raised a total of $2.8M across 1 funding round:
Angel/Seed
$2.8M
Angel/Seed (2023): $2.8M with participation from Break Trail Ventures and M13
Key Investors in Parable
Break Trail Ventures
Break Trail Ventures is an early stage venture fund that partners with entrepreneurs who prioritize customer needs and address significant challenges in their industries.
M13
M13 is an early-stage venture capital firm focused on seed and Series A investments in visionary founders, utilizing a team of full-time operators to help startups scale.
What's next for Parable?
Looking ahead, Parable is poised to utilize its recent capital injection to scale its distribution channels and enhance its research and development capabilities. The strategic focus will likely shift toward market penetration and brand awareness, ensuring that its cognitive wellness products reach a broader demographic. As the company matures, the emphasis will remain on maintaining product integrity while navigating the complexities of the nutritional supplement industry. With the backing of seasoned venture partners, Parable is strategically aligned to capitalize on the increasing consumer interest in proactive brain health management, setting the stage for long-term sustainable growth and potential market leadership.
See full Parable company page
